In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 1, 1997, Pages 27-32

  Ho, Y I I ^a   Chan, C Y ^a   Cheng, A F B ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOCYCLITOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CAPREOMYCIN; GENTAMICIN; KANAMYCIN; STREPTOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIOSTASIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

AMIKACIN; ANTI-BACTERIAL AGENTS; CAPREOMYCIN SULFATE; DRUG RESISTANCE, MICROBIAL; GUANIDINES; HEXOSAMINES; HONG KONG; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY; STREPTOMYCIN;

EID: 0030855743     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.1.27     Document Type: Article

References (32)

1. Brudney, K. & Dobkin, J. (1991). Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. American Review of Respiratory Disease 144, 745-9.
2. Sudre, P., ten Dam, G. & Kochi, A. (1992). Tuberculosis: a global overview of the situation today. Bulletin of the World Health Organization 70, 149-59.
3. Frieden, T. R., Sterling, T., Pablos-Mendez, A., Kilburn, J. O., Cauthen, G. M. & Dooley, S. W. (1993). The emergence of drug-resistant tuberculosis in New York City. New England Journal of Medicine 328, 521-6.
4. Vareldzis, B. P., Grosset, J., de Kantor, I., Crofton, J., Laszlo, A., Felten, M. et al. (1993). Laboratory Evaluations of Drug Resistant Tuberculosis. WHO/TB/93, 171. World Health Organization, Geneva.
5. Hawkins, C. C., Gold, J. W. M., Whimbey, E., Kiehn, T. E., Brannon, P., Cammarata, R. et al. (1986). Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 105, 184-8.
6. Young, L. S. (1988). Mycobacterium avium complex infection. Journal of Infectious Diseases 157, 863-7.
7. Woods, G. L. & Washington, J. A. (1987). Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Reviews of Infectious Diseases 9, 275-94.
8. Wallace, R. J., Swenson, J. M., Silcox, V. A., Good, R. C., Tschen, J. A. & Stone, M. S. (1983). Spectrum of disease due to rapidly growing mycobacteria. Reviews of Infectious Diseases 5, 657-79.
9. Dutt, A. K. & Stead, W. W. (1979). Long-term results of medical treatment in Mycobacterium intracellulare infection. American Journal of Medicine 67, 449-53.
10. Rosenzweig, D. Y. (1979). Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Chest 75, 115-9.
11. Wolinsky, E. (1979). Nontuberculous mycobacteria and associated diseases. American Review of Respiratory Disease 119, 107-59.
12. Kochi, A., Vareldzis, B. & Styblo, K. (1993). Multidrug-resistant tuberculosis and its control. Research in Microbiology 144, 104-10.
13. Lambert, H. P. & O'Grady, F. W. (1992). Aminoglycoside and aminocyclitols. In Antibiotics and Chemotherapy, 6th edn, pp. 1-26. Churchill Livingstone, Edinburgh, UK.
14. McClatchy, J. K. (1986). Antimycobacterial drugs. In Antibiotics in Laboratory Medicine, 2nd edn (Lorian, V., Ed.), pp. 181-222. Williams & Wilkins, Baltimore, MD.
15. Heifets, L. & Lindholm-Levy, P. (1989). Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis. Antimicrobial Agents and Chemotherapy 33, 1298-301.
16. Jedlickova, Z., Sulova, J. & Spurna, M. (1967). Tuberculostatic effect of gentamicin in vitro. Journal of Hygiene, Epidemiology, Microbiology and Immunology 11, 516-7.
17. Waitz, J. A. & Weinstein, M. J. (1969). Recent microbiological studies with gentamicin. Journal of Infectious Diseases 119, 355-60.
18. Sanders, W. E., Cacciatore, R., Valdez, H., Pejovic, I. & Dunbar, F. P. (1971). Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice. Journal of Infectious Diseases 124, Suppl., S33-6.
19. Tanzil, H. O. K. & Utomo, R. R. (1974). Comparative in vitro activity of kanendomycin, kanamycin, gentamicin and streptomycin against 100 consecutive cultures of tubercle bacilli recovered from patients. Paediatrica Indonesiana 11, 27-31.
20. Gangadharam, P. R. J. & Candler, E. R. (1977). In vitro anti-mycobacterial activity of some new amino-glycoside antibiotics. Tubercle 58, 35-8.
21. Barza, M. & Lauermann, M. (1978). Why monitor serum levels of gentamicin? Clinical Pharmacokinetics 3, 201-15.
22. Jedlickova, Z. & Sulova, J. (1975). In-vitro bacteriological study of a new antibiotic substance: sisomicin. Zentralblatt Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene [Orig. A] 230, 104-11.
23. Sande, M. A. & Mandell, G. L. (1980). Antimicrobial agents - the aminoglycosides. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 6th edn (Gilman, A. G., Goodman, L. S. & Gilman, A., Eds), p. 1175. Macmillan Publishing Co., New York, NY.
24. Kotecha, B. & Richardson, G. P. (1994). Ototoxicity in vitro: effects of neomycin, gentamicin, dihydrostreptomycin, amikacin, spectinomycin, neamine, spermine and poly-L-lysine. Hearing Research 73, 173-84.
25. Inderlied, C. B., Kolonoski, P. T., Wu, M. & Young, L. S. (1989). Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice. Antimicrobial Agents and Chemotherapy 33, 176-80.
26. Khardori, N., Rolston, K., Rosenbaum, B., Hayat, S. & Bodey, G. P. (1989). Comparative in-vitro activity of twenty antimicrobial agents against clinical isolates of Mycobacterium avium complex. Journal of Antimicrobial Chemotherapy 24, 667-73.
27. Heifets, L B., Lindholm-Levy, P. J. & Comstock, R. D. (1992). Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium. Antimicrobial Agents and Chemotherapy 36, 1695-8.
28. Wallace, R. J., Dalovisio, J. R. & Pankey, G. A. (1979). Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonae to antibacterial agents. Antimicrobial Agents and Chemotherapy 16, 611-4.
29. Welch, D. F. & Kelly, M. T. (1979). Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrobial Agents and Chemotherapy 15, 754-7.
30. Swenson, J. M., Thornsberry, C. & Silcox, V. A. (1982). Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrobial Agents and Chemotherapy 22, 186-92.
31. Swenson, J. M., Wallace, R. J., Silcox, V. A. & Thornsberry, C. (1985). Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrobial Agents and Chemotherapy 28, 807-11.
32. Hansen, K. T., Clark, R. B. & Sanders, W. E. (1994). Effects of different test conditions on the susceptibility of Mycobacterium fortuitum and Mycobacterium chelonae to amikacin. Journal of Antimicrobial Chemotherapy 33, 483-94.